Capital International Investors Rubius Therapeutics, Inc. Transaction History

Capital International Investors

  • $504 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$0.79 - $5.98 $328,952 - $2.49 Million
-416,396 Closed
0 $0
Q4 2018

Feb 14, 2019
SELL
$13.83 - $22.97 $2.35 Million - $3.9 Million
-170,000 Reduced 28.99%
416,396 $6.09 Million
Q3 2018

Nov 14, 2018
BUY
$20.06 - $26.94 $11.8 Million - $15.8 Million
586,396 New
586,396 $12.5 Million

Others Institutions Holding RUBY

# of Institutions
2
Shares Held
325
Call Options Held
0
Put Options Held
0
View Full List

About Rubius Therapeutics, Inc.

RUBY Quotes by TradingView
  • Ticker RUBY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 90,357,000
  • Description
  • Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of red cell therapeutics (RCTs) for the treatment of patients with severe diseases. The company is developing RTX-240 and RTX-224 for the treatment of solid tumors cancer; and RTX-aAPC to treat cancers. It is also developing RTX-321 for the treatmen...
More about RUBY
Track This Portfolio

Track Capital International Investors Portfolio

Follow Capital International Investors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital International Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital International Investors with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email